Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteers

This publication has 50 references indexed in Scilit:

• High‐Dose Recombinant Canarypox Vaccine Expressing HIV‐1 Protein, in Seronegative Human Subjects
  The Journal of Infectious Diseases, 2005
• Cross‐Reactivity of Anti–HIV‐1 T Cell Immune Responses among the Major HIV‐1 Clades in HIV‐1–Positive Individuals from 4 Continents
  The Journal of Infectious Diseases, 2005
• The Presence of Anti‐Tat Antibodies Is Predictive of Long‐Term Nonprogression to AIDS or Severe Immunodeficiency: Findings in a Cohort of HIV‐1 Seroconverters
  The Journal of Infectious Diseases, 2005
• Potent enhancement of cellular and humoral immune responses against recombinant hepatitis B antigens using AS02A adjuvant in healthy adults
  Vaccine, 2005
• Helping the CD8+ T-cell response
  Nature Reviews Immunology, 2004
• Relationship between Antibody-Dependent Cellular Cytotoxicity, Plasma HIV Type 1 RNA, and CD4⁺Lymphocyte Count
  AIDS Research and Human Retroviruses, 2001
• QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immmunization in humans
  Published by Elsevier ,2001
• Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteers
  AIDS, 1998
• Importance of the nef gene for maintenance of high virus loads and for development of AIDS
  Cell, 1991
• Cellular uptake of the tat protein from human immunodeficiency virus
  Cell, 1988